Brendan De Kauwe is a Director and Founder at SOLIS. He possess expertise in ipo, investor relations, equities, financial structuring, corporate advisory and 17 more skills.
-
Director And FounderSolisSingapore -
Director & Founder SolisSolis Jan 2021 - PresentWeb3Accessible and inclusive entertainment.SOLIS Group is collective of companies, creating a self-sustaining synergistic ecosystem to finance, produce and monetize content.www.solis.io #DeFi #web3 #RWA
-
CpoAladdin Aldd (Aeon) Nov 2023 - PresentSingaporeAI, DePIN, Web3 Gaming Tech & Wearables, SocialFi
-
DirectorAttollo - Investment Banking & Venture Capital Feb 2015 - PresentPrivate Investment Banking and Corporate Advisory.Equity Capital Markets and Debt Financing.
-
Responsible ManagerSharex Sep 2021 - PresentAustraliaFinancial Services Licensor
-
FounderScoundrel 2007 - PresentMusic Publishing & Production
-
Director & Responsible ManagerAkela Capital Apr 2018 - Dec 2020Investment platform for public and private securities offerings. Responsible Manager for Australian Financial Services Licence (Retail and Wholesale Securities).
-
DirectorOokami Jun 2015 - Nov 2020Blockchain venture company with a portfolio of synergistic companies that disrupt data and advertising markets, investment platforms and software as a service (SaaS). Ookami held an ecosystem of advanced technology solutions encompassing ‘smart contracts’ and blockchain technologies, secure identity management and verification (‘Know Your Client’) (KYC) and anti-money laundering (AML) applications, data markets, advertising analytics, investment platforms and security and encryption applications.
-
DirectorRace Oncology Ltd Jul 2016 - Apr 2018ASX: RACZantrene® (bisantrene dihydrochloride) is a small molecule anti-cancer drug which has clinical and preclinical efficacy as both a low dose, highly targeted precision oncology agent and a high dose, less cardiotoxic chemotherapeutic.
-
DirectorInvestia Technologies Apr 2012 - Nov 2015FinTech platform for the listing, marketing and client management of public and private equity offerings.
-
Executive ChairmanActinogen Ltd Apr 2014 - Jan 2015
-
Executive DirectorActinogen Ltd Sep 2013 - Jan 2015ASX: ACWActinogen Medical is an ASX-listed, biotechnology company developing an innovative treatment for cognitive impairment associated with neurological diseases amenable to modifications of raised cortisol levels inside brain cells.
-
DirectorPtx (Prescient Therapeutics) Sep 2013 - Dec 2014ASX: PTXFormerly Virax Holdings Ltd (ASX:VHL)
Brendan De Kauwe Skills
Brendan De Kauwe Education Details
-
Corporate Finance -
Sound Engineering -
Cert Multimedia
-
Rg146 Securities Advisor Compliance
-
Bachelor Of Dental Surgery (Bdsc) -
Studied - Pharmacology & Physiology
Frequently Asked Questions about Brendan De Kauwe
What company does Brendan De Kauwe work for?
Brendan De Kauwe works for Solis
What is Brendan De Kauwe's role at the current company?
Brendan De Kauwe's current role is Director and Founder.
What schools did Brendan De Kauwe attend?
Brendan De Kauwe attended Kaplan University, Sae Institute Australia, Sae Institute Australia, Kaplan University, The University Of Western Australia, The University Of Western Australia.
What skills is Brendan De Kauwe known for?
Brendan De Kauwe has skills like Ipo, Investor Relations, Equities, Financial Structuring, Corporate Advisory, Biotechnology, Lifesciences, Technical Analysis, Financial Modeling, Venture Capital, Private Placements, Due Diligence.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial